Table 4.

Results for final multivariate linear mixed model of fatigue (modified Fatigue Severity Scale) on laboratory, clinical, and patient-reported measures of disease activity and function in the context of comorbidity, medication status, age, sex, and arthritis duration.

VariableEstimateSEt valuep
Intercept6.62690.454614.578< 0.0001
Sex (male vs female)−0.05880.1769−0.3320.740
Age−0.00850.0076−1.1110.267
Arthritis duration−0.00150.0101−0.1490.882
Morning stiffness (yes vs no)0.18910.11151.6960.090
HAQ1.29230.15578.300< 0.0001
SF-36 pain scale−0.01890.0026−7.380< 0.0001
SF-36 mental health scale−0.02750.0027−10.152< 0.0001
Diagnosis of fibromyalgia (yes vs no)0.81610.36252.2510.024
Ever had hypertension (yes vs no)0.30070.13562.2180.027
Ever used methotrexate (yes vs no)0.38360.13412.8590.004
Interaction of arthritis duration with fibromyalgia0.03860.01562.4740.0133
Interaction of morning stiffness with fibromyalgia0.42430.19992.1230.034
Interaction of HAQ with fibromyalgia−0.69540.2176−3.1960.001
Variance componentsVarianceSD
  Between patients2.08111.4426
  Within patient1.50541.2270
  No. of records1534
No. of patients with 2 or more visits385
  • HAQ: Health Assessment Questionnaire; SF-36: Medical Outcomes Study Short Form-36.